India's obesity crisis is intensifying, with big pharma companies like Eli Lilly and Novo Nordisk competing to introduce ...

A new study has found that a once-weekly injection of semaglutide, a medication originally developed for diabetes and weight ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...